Please provide your email address to receive an email when new articles are posted on . Cigna now covers canaloplasty and goniotomy procedures for the treatment of primary open-angle glaucoma. The ...
Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...
Please provide your email address to receive an email when new articles are posted on . CORONADO, Calif. — Both IOP and number of medications were reduced at 12 months in patients who underwent ...
RANCHO CUCAMONGA, Calif., Oct. 14, 2020 /PRNewswire/ -- New World Medical, a global medical device company focused on glaucoma treatment, today announced FDA registration of the KDB® GLIDE™ as a Class ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Goniotomy was greeted as a step forward in the treatment of pediatric glaucoma, but it has been less successful in achieving sustained intraocular pressure (IOP) reductions in adult patients with ...
Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...
For Micro-Invasive Glaucoma Surgery (MIGS) and goniotomy procedures, Volk's new Surgical Gonio Lens provides clear anterior chamber angle images. With a 1.2x image magnification, the contact lens' ...
In a retrospective study, CU ophthalmology researchers found using pilocarpine eye drops following some goniotomy procedures may improve surgical success. “The KDB goniotomy is a minimally invasive ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MENLO PARK, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results